Literature DB >> 17376350

Bacteriology of the sinus cavities of asymptomatic individuals after endoscopic sinus surgery.

Hasan Al-Shemari1, Walid Abou-Hamad, Michael Libman, Martin Desrosiers.   

Abstract

OBJECTIVE: To determine the resident flora and the level of bacterial presence of the healthy sinus cavity post-endoscopic sinus surgery (ESS).
SETTING: University-based prospective trial.
METHOD: Subjects included asymptomatic patients who had undergone ESS for inflammatory disease more than 12 weeks previously. Endoscopic cultures of the sinus cavities were performed with swab and a novel lavage technique and were processed for identification of bacterial species and the level of bacterial presence.
RESULTS: Thirty-two patients were recruited. Bacterial organisms were recovered in 97% of subjects (mean 1.5 organisms/patient). The flora predominantly consisted of coagulase-negative staphylococci (69%) and diphtheroids (25%). Staphylococcus aureus was recovered in 31% of subjects and Pseudomonas aeruginosa in 3% only. No gram-negative rods were recovered in any individual. The Gram stains of 29 individuals were identified; 20 (69%) had no white blood cells, 9 (31%) had 1+ white blood cells, and none had >1 white blood cells. All quantitative lavage fluid cultures were negative at the 10(4) detection level.
CONCLUSION: Coagulase-negative staphylococci, diphtheroids, and S. aureus constitute the predominant flora of the healthy post-ESS sinus cavity and probably represent colonization of the cavity by nasal flora from the contiguous nasal mucosa. These data offer a basis for interpreting sinus cultures obtained in symptomatic patients after ESS. S. aureus may be frequently recovered in asymptomatic patients; thus, not all instances of S. aureus recovery on culture require therapy. Future testing of individuals with this organism will probably have to be modified to better assess factors associated with pathogenicity, such as bacterial load, biofilm formation, or superantigen production. In contrast, gram-negative rods and P. aeruginosa should probably be treated when identified on culture.

Entities:  

Mesh:

Year:  2007        PMID: 17376350     DOI: 10.2310/7070.2006.0019

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  8 in total

1.  Coagulase-negative Staphylococcus culture in chronic rhinosinusitis.

Authors:  Zi Zhang; Nithin D Adappa; Ebbing Lautenbach; Alexander G Chiu; Laurel J Doghramji; Noam A Cohen; James N Palmer
Journal:  Int Forum Allergy Rhinol       Date:  2014-11-03       Impact factor: 3.858

Review 2.  Genetics of rhinosinusitis.

Authors:  Leandra Mfuna-Endam; Yuan Zhang; Martin Y Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

3.  Determination of the biofilm formation capacity of bacterial pathogens associated with otorhinolaryngologic diseases in the Malaysian population.

Authors:  Yalda Khosravi; Lina Chooi Ling; Mun Fai Loke; Sivalingam Shailendra; Narayanan Prepageran; Jamuna Vadivelu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-24       Impact factor: 2.503

4.  Osteosarcoma of the skull base presenting as a petrocavernous pseudoaneurysm and masquerading as an intracranial abscess: illustrative case.

Authors:  Nyomi R Washington; John L Kiley; Hans Bakken; Ryan Morton
Journal:  J Neurosurg Case Lessons       Date:  2021-07-05

Review 5.  The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis.

Authors:  Shaun J Kilty; Martin Y Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

6.  Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.

Authors:  Achim G Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

7.  Staphylococcus aureus on Sinus Culture Is Associated With Recurrence of Chronic Rhinosinusitis After Endoscopic Sinus Surgery.

Authors:  Anastasios Maniakas; Marc-Henri Asmar; Axel E Renteria Flores; Smriti Nayan; Saud Alromaih; Leandra Mfuna Endam; Martin Y Desrosiers
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

8.  Intranasal Application of Lactococcus lactis W136 Is Safe in Chronic Rhinosinusitis Patients With Previous Sinus Surgery.

Authors:  Leandra Mfuna Endam; Saud Alromaih; Emmanuel Gonzalez; Joaquin Madrenas; Benoit Cousineau; Axel E Renteria; Martin Desrosiers
Journal:  Front Cell Infect Microbiol       Date:  2020-10-12       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.